http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013011880-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate | 2011-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e08d2464ec8e79e4e810339fff44dccb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b768823ea0db540c2a3b9f7d4c2a6d6 |
| publicationDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112013011880-B1 |
| titleOfInvention | medical device for local vascular administration of adenosine a2a receptor agonists to reduce myocardial injury |
| abstract | local vascular administration of adenosine a2a receptor agonists to reduce myocardial injury The present invention relates to a stent or other implantable medical device for local administration of an adenosine receptor agonist may be used to reduce following myocardial injury to an acute myocardial infarction. As soon as possible following acute myocardial infarction, a stent or other suitable device comprising and capable of administering an adenosine receptor agonist is positioned in the blood vessel with the occlusion responsible for causing the infarction. Once in position, the stent or other intraluminal device is deployed to remove occlusion and reestablish blood flow to the specific area, region or volume of heart tissue. for a period of time the adenosine receptor agonist elutes from the stent or other device for downstream coronary blood flow to hypoxic cardiac tissue for a time sufficient to reduce the level of myocardial injury. |
| priorityDate | 2010-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.